Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

26.37
+0.42501.64%
Volume:21.02M
Turnover:549.24M
Market Cap:149.42B
PE:18.67
High:26.40
Open:25.93
Low:25.91
Close:25.94
Loading ...

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos

Dow Jones
·
24 Feb

BUZZ-Summit Therapeutics rises on clinical trial collaboration with Pfizer

Reuters
·
24 Feb

Summit Therapeutics Inc - Clinical Trials Expected to Start Mid-Year

THOMSON REUTERS
·
24 Feb

Summit Therapeutics - Under Terms of Agreement, Co to Provide Ivonescimab, Pfizer to Conduct Study Operations

THOMSON REUTERS
·
24 Feb

Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)

Business Wire
·
24 Feb

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Motley Fool
·
24 Feb

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold Forever

Motley Fool
·
23 Feb

Pfizer Inc. (PFE): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Insider Monkey
·
23 Feb

3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade

Motley Fool
·
22 Feb

Why Viking Therapeutics Inc. (VKTX) Surged On Friday?

Insider Monkey
·
22 Feb

Why Moderna Inc. (MRNA) Surged On Friday?

Insider Monkey
·
22 Feb

BRIEF-Trump Told Drugmakers To Move Production To US Or Face Tariffs- Bloomberg News

Reuters
·
22 Feb

Trump Told Drugmakers to Move Production to US or Face Tariffs- Bloomberg News

THOMSON REUTERS
·
22 Feb

Chinese researchers find bat virus enters human cells via same pathway as COVID

Reuters
·
22 Feb

Pfizer Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
22 Feb

Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?

Benzinga
·
22 Feb